References
- Fihn S D, Stamm W E. Interpretation and comparison of treatment studies for uncomplicated urinary tract infections in women. Rev Infect Dis 1985; 7: 468–478
- Norrby S R. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis 1990; 12: 458–467
- Morrison P J, Mant T GK, Norman G T, Robinson J, Kunka R L. Pharmacokinetics and tolerance of lomefloxacin after sequentially increasing oral doses. Antimicrob Agents Chemother 1988; 32: 1503–1507
- Wise R, Andrews J M, Ashby J P, Matthews R S. In vitro activity of lomefloxacin, a new quinolone antimicrobial agent, in comparison with those of other agents. Antimicrob Agents Chemother 1988; 32: 617–622
- Ericsson H M, Sherris J C. Antibiotic sensitivity testing. Report of an international collaborative study. Acta Pathol Microbiol Immunol Scand 1971; 79(Suppl B)217
- The Inter-Nordic Urinary Tract Infection Study Group. Double-blind comparison of 3-day versus 7-day treatment with norfloxacin in symptomatic urinary tract infections. Scand J Infect Dis 1988; 20: 619–624
- Piippo T, Pitkäjärvi T, Salo S A. Three-day versus seven-day treatment with norfloxacin in acute cystitis. Curr Ther Res 1990; 47: 644–653